ETRADE Capital Management LLC trimmed its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 5.6% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 20,771 shares of the pharmacy operator’s stock after selling 1,221 shares during the quarter. ETRADE Capital Management LLC’s holdings in Walgreens Boots Alliance were worth $1,627,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of WBA. Hudock Capital Group LLC boosted its position in shares of Walgreens Boots Alliance by 0.5% in the 2nd quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock worth $102,000 after purchasing an additional 6 shares in the last quarter. Reilly Financial Advisors LLC boosted its position in shares of Walgreens Boots Alliance by 7.9% in the 2nd quarter. Reilly Financial Advisors LLC now owns 1,367 shares of the pharmacy operator’s stock worth $107,000 after purchasing an additional 100 shares in the last quarter. Orrstown Financial Services Inc. boosted its position in shares of Walgreens Boots Alliance by 14.1% in the 2nd quarter. Orrstown Financial Services Inc. now owns 1,728 shares of the pharmacy operator’s stock worth $135,000 after purchasing an additional 213 shares in the last quarter. Private Vista LLC boosted its position in shares of Walgreens Boots Alliance by 6,403.7% in the 2nd quarter. Private Vista LLC now owns 583,185 shares of the pharmacy operator’s stock worth $140,000 after purchasing an additional 574,218 shares in the last quarter. Finally, Hanson McClain Inc. boosted its position in shares of Walgreens Boots Alliance by 4.6% in the 2nd quarter. Hanson McClain Inc. now owns 1,987 shares of the pharmacy operator’s stock worth $156,000 after purchasing an additional 87 shares in the last quarter. 63.58% of the stock is currently owned by institutional investors and hedge funds.

In related news, Director John Anthony Lederer acquired 20,000 shares of Walgreens Boots Alliance stock in a transaction dated Thursday, October 26th. The stock was purchased at an average cost of $67.00 per share, for a total transaction of $1,340,000.00. Following the purchase, the director now directly owns 50,000 shares of the company’s stock, valued at approximately $3,350,000. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction on Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total value of $184,324.32. Following the completion of the sale, the director now owns 16,415 shares of the company’s stock, valued at $1,105,878.55. The disclosure for this sale can be found here. Corporate insiders own 13.50% of the company’s stock.

WARNING: “ETRADE Capital Management LLC Cuts Holdings in Walgreens Boots Alliance, Inc. (WBA)” was originally published by Watch List News and is the property of of Watch List News. If you are viewing this story on another domain, it was stolen and reposted in violation of US and international trademark & copyright legislation. The legal version of this story can be accessed at https://www.watchlistnews.com/etrade-capital-management-llc-cuts-holdings-in-walgreens-boots-alliance-inc-wba/1708774.html.

A number of analysts have recently commented on WBA shares. Jefferies Group LLC reissued a “buy” rating and issued a $95.00 price target on shares of Walgreens Boots Alliance in a research report on Monday, October 2nd. Needham & Company LLC reissued a “buy” rating and issued a $94.00 price target on shares of Walgreens Boots Alliance in a research report on Saturday, September 16th. Loop Capital started coverage on Walgreens Boots Alliance in a research report on Thursday, August 24th. They issued a “buy” rating and a $95.00 price target on the stock. UBS AG reissued a “buy” rating and issued a $96.00 price target (down from $97.00) on shares of Walgreens Boots Alliance in a research report on Wednesday, August 23rd. Finally, Mizuho set a $94.00 price target on Walgreens Boots Alliance and gave the stock a “buy” rating in a research report on Tuesday, October 24th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus price target of $87.63.

Shares of Walgreens Boots Alliance, Inc. (WBA) opened at $71.30 on Friday. The company has a quick ratio of 0.59, a current ratio of 1.07 and a debt-to-equity ratio of 0.45. The company has a market capitalization of $70,870.34, a price-to-earnings ratio of 13.77, a PEG ratio of 1.25 and a beta of 1.20. Walgreens Boots Alliance, Inc. has a 12 month low of $63.82 and a 12 month high of $88.00.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Wednesday, October 25th. The pharmacy operator reported $1.31 EPS for the quarter, topping the consensus estimate of $1.21 by $0.10. The firm had revenue of $30.15 billion during the quarter, compared to analyst estimates of $29.93 billion. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. Walgreens Boots Alliance’s revenue was up 5.3% on a year-over-year basis. During the same period in the prior year, the business posted $1.07 EPS. research analysts anticipate that Walgreens Boots Alliance, Inc. will post 5.55 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Monday, November 13th will be paid a $0.40 dividend. The ex-dividend date is Friday, November 10th. This represents a $1.60 annualized dividend and a dividend yield of 2.24%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 42.33%.

Walgreens Boots Alliance announced that its board has approved a stock repurchase program on Wednesday, October 25th that authorizes the company to repurchase $1.00 billion in shares. This repurchase authorization authorizes the pharmacy operator to repurchase shares of its stock through open market purchases. Stock repurchase programs are often a sign that the company’s board of directors believes its stock is undervalued.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.